CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC

Clinical trial NCT07413757 · RECRUITING

Trial details

NCT number: NCT07413757
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer

Start date: 2026-03-02
Primary completion: 2026-07-31
Enrollment: 590

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.